Cargando…

Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity

Hepatocellular carcinoma (HCC) accounts for 90% of liver tumours and is one of the leading causes of mortality. Cirrhosis due to viral hepatitis, alcohol or steatohepatitis is the major risk factor, while liver dysfunction due to cirrhosis is a deciding factor in its treatment. The treatment modalit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewis, Shirley, Dawson, Laura, Barry, Aisling, Stanescu, Teodor, Mohamad, Issa, Hosni, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289870/ https://www.ncbi.nlm.nih.gov/pubmed/35860434 http://dx.doi.org/10.1016/j.jhepr.2022.100498

Ejemplares similares

MRI-Guided Online Adaptive Stereotactic Body Radiation Therapy of Liver and Pancreas Tumors on an MR-Linac System
por: Stanescu, Teo, et al.
Publicado: (2022)

Substantial Distortion of the Aorta During Celiac Plexus Stereotactic Body Radiation: A Case Report
por: Keilty, Dana, et al.
Publicado: (2022)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies
por: Schaub, Stephanie K., et al.
Publicado: (2018)

Local Control Following Stereotactic Body Radiation Therapy for Liver Oligometastases: Lessons from a Quarter Century
por: Mheid, Sara, et al.
Publicado: (2023)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Venkat, Puja S., et al.
Publicado: (2017)

The Evolving Role of Stereotactic Body Radiation Therapy for Head and Neck Cancer: Where Do We Stand?
por: Mohamad, Issa, et al.
Publicado: (2023)

Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular Carcinoma
por: Yoon, Sang Min, et al.
Publicado: (2013)

Repeated CyberKnife stereotactic body radiation therapy in hepatocellular carcinoma
por: Sun, Jing, et al.
Publicado: (2020)

Stereotactic Body Radiation Therapy for the Management of Hepatocellular Carcinoma: Efficacy and Safety
por: Roquette, Isaure, et al.
Publicado: (2022)

Stereotactic body radiation therapy as an effective and safe treatment for small hepatocellular carcinoma
por: Zhang, Tao, et al.
Publicado: (2018)

Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review
por: Gerum, Sabine, et al.
Publicado: (2019)

The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC)
por: Kimura, Tomoki, et al.
Publicado: (2022)

Establishing the Role of Stereotactic Ablative Body Radiotherapy in Early-Stage Breast Cancer
por: Barry, Aisling, et al.
Publicado: (2018)

Clinical significance of radiation-induced liver disease after stereotactic body radiation therapy for hepatocellular carcinoma
por: Jun, Baek Gyu, et al.
Publicado: (2018)

Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity
por: Liang, Ping, et al.
Publicado: (2016)

Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
por: Gerum, Sabine, et al.
Publicado: (2018)

Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma
por: Oldrini, Guillaume, et al.
Publicado: (2017)

Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant
por: Wong, Tiffany Cho‐Lam, et al.
Publicado: (2021)

Practical Considerations for the Implementation of a Stereotactic Body Radiation Therapy Program for Oligo-Metastases
por: Chan, Matthew, et al.
Publicado: (2020)

Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm
por: Su, Ting-Shi, et al.
Publicado: (2016)

Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery
por: Kim, Mi-Sook, et al.
Publicado: (2015)

The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities
por: Que, Jenny Y, et al.
Publicado: (2014)

Analysis of the factors affecting the safety of robotic stereotactic body radiation therapy for hepatocellular carcinoma patients
por: Liu, Xiaojie, et al.
Publicado: (2017)

Defining Radiation-Induced Hepatic Toxicity in Hepatocellular Carcinoma Patients Treated with Stereotactic Body Radiotherapy
por: Song, Jin Ho, et al.
Publicado: (2017)

Impact of tumor size on outcome after stereotactic body radiation therapy for inoperable hepatocellular carcinoma
por: Kuo, Hsing-Tao, et al.
Publicado: (2017)

Is higher dose always the right answer in stereotactic body radiation therapy for small hepatocellular carcinoma?
por: Lee, Kyung Hwa, et al.
Publicado: (2018)

Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma
por: Que, Jenny, et al.
Publicado: (2016)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients With Child-Pugh B or C Cirrhosis
por: Lee, Peter, et al.
Publicado: (2020)

Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma—Consideration of the Locations of Target Lesions
por: Yano, Shigeki, et al.
Publicado: (2023)

Stereotactic Body Radiation Therapy versus Surgical Resection for Stage I/II Hepatocellular Carcinoma
por: Birgin, Emrullah, et al.
Publicado: (2023)

Huge Hepatocellular Carcinoma Exhibiting a Complete Response after Stereotactic Body Radiation Therapy
por: Shin, Kyung In, et al.
Publicado: (2020)

Fiducial Markers Allow Accurate and Reproducible Delivery of Liver Stereotactic Body Radiation Therapy
por: Moskalenko, Marina, et al.
Publicado: (2023)

Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis
por: Choi, Byung Ock, et al.
Publicado: (2008)

Successful Treatment of Stereotactic Body Radiation Therapy Combined with Transarterial Chemolipiodolization for Hepatocellular Carcinoma with Biliary Obstruction
por: Park, Chan-Kwon, et al.
Publicado: (2011)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2013)

Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival
por: Robbins, Jared R., et al.
Publicado: (2019)

CyberKnife Stereotactic Body Radiation Therapy as an Effective Treatment for Hepatocellular Carcinoma Patients With Decompensated Cirrhosis
por: Sun, Jing, et al.
Publicado: (2020)

Outcomes After Stereotactic Body Radiation Therapy as a Bridging Modality to Liver Transplantation for Hepatocellular Carcinoma
por: Garg, Rashi, et al.
Publicado: (2020)

Transarterial Chemoembolization with LC Bead LUMI followed by Stereotactic Body Radiation Therapy in Treatment of Hepatocellular Carcinoma
por: Isaac, Evrosina I., et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy (SBRT) Plus Immune Checkpoint Inhibitors (ICI) in Hepatocellular Carcinoma and Cholangiocarcinoma
por: Jiang, Joanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_318f4381rb2nlhjq6lr2almuu8